Skip to content

Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study

Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study - JSTM-PROS01HR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050538
Enrollment
200
Registered
2023-03-08
Start date
2023-03-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Sponsors

Aichi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with high-risk prostate cancer 2) Patients undergoing radiotherapy and hyperthermia 3) Patients who are 20 years of age or older at the time of enrollment 4) Patients with an ECOG Performance Status (PS) of 0 to 2 5) Patients expected to survive more than 3 months

Exclusion criteria

Exclusion criteria: 1) Patients with multiple cancers (simultaneous multiple cancers or iatrogenic multiple cancers with a disease-free interval of 5 years or less).However, intraepithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer are not included in overlapping cancers. 2) Patients who have a history of irradiation (re-irradiation) at the same site as the current irradiation. 3) Patients who will be treated with three-dimensional source body irradiation 4) Patients who will not receive concomitant endocrine therapy 5) Patients who are scheduled to receive concomitant small source radiation therapy 6) Patients who are judged by the principal investigator to be inappropriate for enrollment in this study.

Design outcomes

Primary

MeasureTime frame
5-year biochemical recurrence-free survival rate

Secondary

MeasureTime frame
3/5/8-year overall/cause-specific /clinical recurrence-free survival rate, Adverse event rate, Transitions in the IPSS and QOL scores

Countries

Japan

Contacts

Public ContactMakoto Ito

Aichi Medical University Hospital Radiology

itou.makoto.292@mail.aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026